Endocanna Health Aims To Increase Genetic Risk Awareness For COVID-19

Endocanna Health Aims To Increase Genetic Risk Awareness For COVID-19

This pandemic is practically unprecedented in terms of how mysterious its risk factors are. While the mode of transmission is known, the exact factors that make a person susceptible to severe complications aren’t. Experts all agree that COVID-19 may either pass the infected with no symptoms, cause mild respiratory effects or in worst-cases deaths. However, what still remains unclear is who is vulnerable and why. That’s why Endocanna Health, a cannabinoid DNA-research company based in California, has stepped up. They are offering a free DNA test for genetic factors in their consumers. This test is meant to scan for known genetic markers that could lead to susceptibility. While the gesture is generous, it must be cautioned such a test is not meant to be a reliable tool to assess this. DNA research works by looking for known markers The aim of Endocanna Health’s test is to examine possible vulnerable genes. Such genes could make a person’s immune system weaker to infection, or allow them to develop worse symptoms. However, if you’re wondering why you haven’t been prescribed this test before, there’s a reason. Most healthcare providers and experts don’t rely on such tests because they only indicate correlation. There is no way to prove the causation. What that means, simply, is that certain genes can make COVID-19 more severe, not always. Factors like age, diet, health conditions and mental health are important too, though. Endocanna Health’s research is most notable for its work on the human ...
More on: cannabishealthinsider.com